Vivos Therapeutics swaps $2.86 million Streeterville note debt for 11,445,080 shares at $0.25 each

PUBT · 1d ago
Vivos Therapeutics swaps $2.86 million Streeterville note debt for 11,445,080 shares at $0.25 each
  • Vivos Therapeutics exchanged USD 2.86 million of Streeterville Note principal for 11,445,080 common shares at USD 0.25 each.
  • The August 31, 2026 exchanges followed a prior USD 3.25 million swap into Series B preferred stock and common shares.
  • Streeterville Note balance fell to about USD 3.7 million from USD 8.23 million originally issued in June 2025.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivos Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609080845PRIMZONEFULLFEED9822771) on September 08, 2026, and is solely responsible for the information contained therein.